patient
haemodialysi
present
high
infecti
morbid
enhanc
carcinoma
incid
impair
wound
heal
reduc
effect
directli
relat
function
immun
system
immunolog
abnorm
leukocyt
describ
patient
dialysi
mphi
monocyt
macrophag
major
effector
immun
system
widespread
microbicid
tumoricid
function
alter
uraemia
uraem
immunodefici
complic
renal
failur
reflect
stress
eg
exert
yet
poorli
defin
uraem
toxin
imbal
antioxid
prooxid
malnutrit
iron
overload
membran
bioincompat
inflamm
therefor
patient
endstag
renal
diseas
esrd
suffer
increas
oxid
stress
ineffect
treat
haemodialysi
respons
human
cell
stress
eg
heat
shock
hs
highli
conserv
adapt
cell
respons
found
cell
life
form
confer
resist
differ
stressor
ie
increas
temperatur
fever
nutrit
defici
oxid
stress
hypoxia
correspond
heat
shock
protein
hsp
like
major
stressinduc
famili
member
hsp
induc
also
found
cell
normal
physiolog
condit
control
fold
protein
constitut
express
bind
newli
translat
immatur
protein
prevent
prematur
improp
bind
fold
vital
sinc
anim
suscept
stress
even
viabl
respons
stress
housekeep
activ
hsp
eg
degrad
unstabl
misfold
protein
control
regulatori
protein
transport
protein
switch
toward
reaction
stress
increas
cell
chanc
surviv
cellular
injuri
decreas
either
induct
cytoresist
enhanc
repair
mechan
thu
induct
confer
protect
even
subleth
damag
caus
apoptosi
therefor
refer
cellular
lifeguard
other
show
injuri
protect
monocyt
note
housekeep
function
hsp
critic
involv
eg
potent
immun
adjuv
innat
adapt
immun
respons
inflamm
infect
tumour
defenc
case
infect
induct
even
crucial
keep
mphi
aliv
therefor
capabl
antihazard
action
sever
factor
pathway
identifi
respons
trigger
caus
immunodefici
patient
esrd
still
underli
mechan
determin
mphi
dysfunct
complex
remain
certain
extent
unknown
thu
address
studi
identifi
reduc
stressrel
respons
mphi
rat
chronic
kidney
diseas
use
hs
simpl
model
feverstress
investig
capac
induct
mphi
patient
intermitt
haemodialysi
ihd
enrol
stabl
patient
male
ihd
mean
age
rang
year
chosen
random
dialysi
unit
univers
hospit
germani
patient
mphi
compar
appar
healthi
volunt
male
medic
present
complaint
activ
patholog
mean
age
ctr
rang
year
statist
signific
differ
age
among
group
studi
patient
haemoglobin
level
gdl
treat
erythropoietin
epoetin
alpha
ie
median
ieweek
iv
intraven
iron
standard
heparin
anticoagul
blood
pressur
control
wherea
patient
receiv
dihydropyridin
calcium
channel
blocker
andor
angiotensinconvert
enzym
inhibitor
respect
reach
normotens
patient
receiv
haemodialysi
h
three
occas
week
month
use
polysulfon
membran
fmc
bad
homburg
germani
bicarbon
dialys
mmoll
contain
mm
na
mm
k
mm
mm
mm
glucos
gl
skf
fmc
dialys
flow
rate
mlmin
blood
flow
mlmin
patient
primari
arterioven
fistula
radiocephal
brachiocephal
two
needl
use
dialysi
session
renal
diagnos
nephrosclerosi
n
inact
glomerulonephr
n
interstiti
nephriti
n
polycyst
kidney
diseas
n
renal
failur
relat
chronic
heart
failur
n
diabet
nephropathi
n
seven
patient
reason
remain
undefin
group
exclus
criteria
follow
haemodialysi
durat
month
pth
pgml
evid
infect
neoplasia
liver
diseas
patient
antibiot
antiinflammatori
immunosuppress
drug
also
exclud
inform
consent
obtain
particip
studi
approv
ethic
committe
univers
hospit
germani
eightweekold
male
rat
charl
river
sulzfeld
germani
free
access
standard
rat
chow
ssniff
soest
germani
tap
water
randomli
assign
surgic
n
control
group
ctr
n
experi
approv
government
committe
anim
welfar
perform
accord
nation
anim
protect
guidelin
short
involv
midlin
incis
remov
right
kidney
select
ligat
branch
left
renal
arteri
surgeri
perform
gener
anaesthesia
ketamin
mgkg
xylazin
mgkg
bodi
weight
bw
measur
surgeri
week
surgeri
serum
paramet
blood
pressur
tail
cuff
plethysmographi
total
kidney
function
record
week
diseas
progress
twentyfour
hour
kidney
recoveri
anim
hous
metabol
cage
urin
blood
sampl
analys
creatinin
enzymat
assay
creatininepap
roch
diagnost
mannheim
germani
bun
ureasegldh
method
protein
bradford
blue
biorad
laboratori
germani
antibodi
obtain
describ
tabl
saponin
dmannitol
purchas
merck
darmstadt
germani
unless
otherwis
indic
reagent
purchas
sigmaaldrich
taufkirchen
germani
portion
kidney
snapfrozen
fix
formaldehyd
pb
histolog
chang
eg
glomerular
sclerosi
vascular
wall
tubular
cast
infiltr
examin
light
microscopi
paraffinembed
tissu
period
acidschiff
stain
blood
sampl
obtain
steril
condit
patient
beforeandaft
first
weekli
dialysi
session
long
interv
respect
rat
trunk
blood
collect
decapit
week
mphi
purifi
publish
short
mphi
separ
heparin
whole
blood
densiti
gradient
separ
ficollhypaqu
biochrom
serom
berlin
germani
monocyt
purifi
adher
cultur
dish
result
final
puriti
cell
wash
seed
plate
greiner
germani
air
atmospher
rpmi
cultur
medium
cm
paa
laboratori
pasch
austria
supplement
mm
lglutamin
penicillinstreptomycin
mm
hepe
mercaptoethanol
hs
mphi
seed
preheat
cm
temperatur
indic
contain
inactiv
fetal
calf
serum
fc
endotoxin
content
ngml
chemic
indic
hs
heat
cm
replac
cm
cell
incub
measur
experi
dmannitol
urea
mphi
incub
cm
cm
mgdl
mannitol
cm
mgdl
urea
hs
perform
h
min
cell
harvest
realtim
pcr
analysi
h
differ
incub
time
temperatur
given
result
figur
legend
fixat
paraformaldehyd
min
wash
cell
incub
stain
buffer
fc
mm
hepe
buffer
saponin
ph
min
label
mous
antihuman
wash
cell
incub
min
secondari
fitclabel
goat
cytofluorometr
analysi
perform
facscan
cytomet
bd
life
scienc
research
total
event
fortyeight
hour
serum
deplet
fc
use
render
mphi
apoptot
simultan
detect
express
annexin
vbind
identifi
apoptot
monocyt
mphi
deem
apoptot
express
low
annexin
vbind
high
mphi
prepar
treat
describ
doublelabel
peconjug
annexin
vfitc
stain
buffer
pb
contain
fc
sodium
azid
ph
min
ice
pe
fitcconjug
murin
igg
mab
unrel
specif
use
control
cell
wash
stain
flow
cytometri
appli
total
event
necrosi
exclud
trypan
blue
stain
messang
rna
express
profil
select
gene
valid
realtim
pcr
total
rna
freshli
isol
monocyt
use
cdna
synthesi
high
capac
cdna
revers
transcript
kit
realtim
pcr
perform
use
sybr
green
pcr
master
mix
abi
prism
sequenc
detect
system
specif
primer
pair
use
amplif
list
tabl
mwgbiotech
ebersberg
germani
instrument
reagent
purchas
appli
biosystem
darmstadt
germani
rel
gene
express
valu
evalu
method
use
gapdh
housekeep
gene
data
present
mean
sd
data
compar
student
ttest
anova
varianc
analysi
multipl
comparison
use
graphpad
prism
graphpad
softwar
la
jolla
ca
usa
signific
infer
p
two
week
subtot
renal
ablat
induc
adapt
remnant
nephron
wherea
kidney
control
present
physiolog
histolog
figur
kidney
show
glomerular
hypertrophi
fibrosi
mild
tubulointerstiti
infiltr
thicken
vessel
muscular
layer
atrophi
detach
epitheli
cell
addit
lumin
proteinac
cast
found
proxim
tubul
figur
function
data
measur
perform
week
given
tabl
abnorm
renal
histolog
accompani
elev
blood
pressur
function
featur
renal
insuffici
creatinin
clearanc
decreas
occur
polyuria
parallel
signific
proteinuria
weight
loss
retent
paramet
ie
serum
creatinin
blood
urea
nitrogen
increas
significantli
twelv
hour
hs
express
mphi
rat
renal
insuffici
n
compar
control
rat
ctr
n
basal
mrna
express
show
differ
mphi
ctr
figur
hs
significantli
increas
monocyt
ctr
significantli
lower
extent
mphi
less
hsctr
n
evalu
effici
set
induct
figur
mphi
isol
six
healthi
subject
expos
min
differ
temperatur
allow
recov
h
induct
strike
exposur
cell
versu
basal
n
estim
extent
induc
remain
detect
hs
sampl
expos
min
allow
recov
variou
time
period
level
mphi
increas
start
h
hs
maxim
valu
appar
h
recoveri
figur
shown
figur
trypan
blue
stain
data
shown
hs
even
appli
subleth
rang
evok
injuri
apoptosi
therefor
monocyt
viabil
maintain
like
hsp
induct
defin
optim
hsstimul
condit
human
mphi
figur
test
initi
hypothesi
hs
respons
mphi
patient
haemodialysi
impair
analog
mphi
rat
without
renal
failur
differ
found
basal
mrnaexpress
level
patient
control
figur
nevertheless
stimul
hs
observ
significantli
increas
mrna
mphi
ctr
patient
next
step
analys
express
respons
transcript
factor
found
significantli
lower
express
hsstimul
mphi
patient
mphi
ctr
figur
c
consist
mrna
data
impair
respons
patient
evid
well
hsp
protein
express
assess
figur
b
differ
found
basal
express
compar
figur
exclud
addit
posttranscript
mechan
possibl
involv
impair
express
mphi
patient
haemodialysi
mphi
incub
either
transcript
inhibitor
actinomycin
without
hs
translat
inhibitor
cycloheximid
without
hs
hour
start
time
hs
treatment
inhibitor
abolish
induct
usual
observ
h
hs
group
extent
exclud
mechan
next
step
investig
urea
respons
trigger
impair
hs
respons
surpris
incub
urea
significantli
increas
mrna
respons
hs
osmot
control
substanc
mannitol
figur
assess
impact
observ
impair
hs
respons
patient
mphi
cellular
suscept
apoptosi
analys
figur
first
baselin
apoptosi
rate
quantifi
level
constitut
apoptot
mphi
cultiv
cm
contain
fc
rather
low
doubl
nearli
mphi
patient
analys
nevertheless
induct
cytoprotect
antiapoptot
hs
respons
hs
reduc
apoptosi
rate
still
apoptosi
rate
patient
mphi
nearli
three
time
higher
patient
ctr
figur
stress
starvat
due
serum
deplet
fraction
apoptot
mphi
significantli
increas
hstreat
cell
effect
protect
apoptosi
apoptosi
rate
treat
ctr
less
third
rate
mphi
patient
one
exemplari
analysi
stressinduc
apoptosi
mphi
shown
figur
c
left
hs
apoptosi
remain
twice
high
patient
mphi
ctr
right
clarifi
haemodialysi
sessionrel
stress
possibl
translat
stimul
patient
mphi
express
mphi
freshli
isol
patient
haemodialysi
investig
differ
observ
figur
uraem
stressrel
dysfunct
mphi
import
contributori
factor
increas
incid
infect
tumour
impair
wound
heal
patient
haemodialysi
herein
show
mphi
rat
renal
insuffici
mphi
patient
ihd
stressrel
induct
import
cytoprotect
antiapoptot
mechan
cell
impair
although
baselin
express
remain
unaffect
reduc
express
accompani
signific
lower
mrna
express
respons
transcript
factor
result
reduc
cellular
resist
proapoptot
stress
upregul
human
monocyt
start
shortli
hs
figur
therefor
confirm
specif
detect
induc
form
chosen
high
rather
long
thermal
stress
lower
stimul
less
effect
figur
express
declin
time
peak
h
figur
still
previous
demonstr
even
h
later
enhanc
rapid
massiv
induct
hsp
act
strongli
antiapoptot
allow
surviv
monocyt
even
thermal
stress
subleth
temperatur
stress
serum
starvat
appli
low
apoptosi
necrosi
rate
figur
result
consist
previou
studi
mostli
analys
cell
line
confirm
role
hsp
confer
resist
physic
stress
proapoptot
trigger
sever
attempt
made
clarifi
mechan
caus
immunodefici
patient
esrd
known
far
mechan
broken
singl
effector
pathway
rather
complex
yet
fulli
understood
interestingli
induct
act
antiapoptot
influenc
mphi
phagocytosi
capac
resist
intracellular
infect
memoli
et
al
state
impair
immunocompet
observ
mphi
patient
ihd
result
chronic
overstimul
caus
proinflammatori
cytokin
complement
activ
toxin
conduct
decreas
reson
stimul
fatigu
nevertheless
could
neither
detect
dialysi
sessiondepend
induct
stimul
find
elev
baselin
patient
figur
rat
renal
insuffici
figur
recent
contrast
data
calabres
et
al
measur
elev
level
lymphocyt
patient
diabet
nephropathi
diabetesrel
stress
patient
metabol
consider
differ
diabet
nondiabet
patient
measur
perform
edtatr
lymphocyt
lead
via
calcium
efflux
pre
deactiv
cellular
pathway
result
may
vari
monocyt
patient
periton
dialysi
exhibit
signific
hs
respons
contact
periton
dialysi
fluid
mean
overstimul
unfortun
studi
lack
healthi
control
protein
potent
immun
adjuv
releas
eg
upon
tissu
damag
regul
immunerespons
also
increas
express
tolllik
receptor
tolllik
receptor
critic
activ
immunocompet
cell
ando
et
al
describ
reduc
express
monocyt
uraem
patient
contribut
impair
cytokin
respons
taken
togeth
reduc
respons
stress
might
caus
less
effect
recognit
harm
antigen
less
activ
pathway
urea
clinic
relev
concentr
mgdl
induc
hs
respons
short
run
h
cultur
neuroblastoma
cell
maddock
westenfeld
charg
protein
carbamyl
trigger
interestingli
hs
respons
return
zero
h
assum
kind
cellular
adapt
long
run
agreement
data
show
baselin
amount
mphi
healthi
rat
increas
serum
bun
figur
ureatr
mphi
figur
well
patient
control
figur
consist
marzec
et
al
monocyt
rat
renal
insuffici
patient
ihd
respond
hs
case
significantli
lower
extent
one
control
figur
contrast
skelet
muscl
chronic
dialysi
patient
steadi
state
contain
increas
amount
protect
hs
protein
notabl
express
longterm
ureaincub
mphi
respond
signific
higher
extent
hs
control
figur
possibl
explan
ureainduc
express
heat
mphi
ureamedi
protein
destabil
may
enhanc
increas
temperatur
sinc
disrupt
protein
tertiari
structur
final
common
pathway
hsp
induct
mechan
could
also
account
ureainduc
express
high
temperatur
malnutrit
frequent
present
patient
ihd
uraemia
chang
plasma
intracellular
amino
acid
level
wherea
ihd
alter
protein
turnov
amino
acid
transport
kinet
critic
ill
patient
decreas
plasma
glutamin
level
caus
impair
monocyt
function
lead
substanti
immunosuppress
glutamin
depriv
increas
mphi
suscept
stress
apoptosi
well
reduc
respons
stimuli
glutamin
starv
reduc
thermoresist
fever
mphi
accord
pollheim
et
al
caus
impair
respons
thu
one
assum
glutamin
deplet
contribut
reduc
respons
favour
apoptosi
demonstr
patient
mphi
figur
nevertheless
acceler
efflux
amino
acid
muscl
protein
catabol
help
stabil
intracellular
concentr
amino
acid
ihd
perform
experi
cm
contain
mm
lglutamin
exclud
undersuppli
effect
alreadi
present
rat
model
chronic
kidney
diseas
henc
glutamin
starvat
probabl
involv
treatment
erythropoietin
induc
organ
like
heart
kidney
exhibit
antiapoptot
cytoprotect
effect
recent
ribeil
et
al
identifi
import
mechan
lead
differenti
human
erythroid
precursor
show
activ
termin
differenti
erythropoietinstarvationinduc
apoptosi
presenc
erythropoietin
protect
erythroid
precursor
caspasemedi
proteolysi
erythropoietin
integr
part
pharmacolog
therapi
esrd
one
specul
untreat
esrd
patient
respons
might
wors
apoptosi
even
elev
addit
respons
alreadi
impair
rat
model
exclud
medic
main
underli
trigger
alter
mphi
stress
respons
result
demonstr
impair
respons
mphi
patient
ihd
accompani
decreas
respons
hs
alarm
impair
stress
respons
necessarili
bound
uraemia
alreadi
present
chronic
kidney
diseas
demonstr
rat
model
patient
mphi
show
enhanc
suscept
stress
eg
serum
starvat
shown
increas
cellular
apoptosi
valu
impair
respons
mphi
might
explain
part
patient
ihd
challeng
higher
incid
infect
tumour
impair
wound
heal
